CNBC: Investing

JUNE 9, 2025

The stock opened that day at $69.69, or 34% above its IPO, and closed up nearly 29% at $67 per share. The overwhelming positive sentiment from Wall Street has rewarded the company's decision to go public after a lengthy dry spell for IPOs. Here's what analysts at some of the biggest shops on Wall Street had to say on the IPO.

IPO 66

IPO Trading IT Retail 66

TechCrunch: M&A

JUNE 26, 2023

“We are so excited to be joining IBM and combining our industry leading offerings with IBM’s global presence and strong portfolio across AIOps, automation and hybrid cloud offerings.” The second is that it’s worth watching to see what happens next across the PE landscape.

Management 50

Management Business Acquisitions IT 50

The TRADE

DECEMBER 15, 2023

Before joining HKEX, she was a partner of Davis Polk & Wardwell from 2010 to 2019, where she oversaw a wide portfolio of clients in Hong Kong and across Asia. Prior to that, she served as the head of IPO transactions, listing division, HKEX from 2007 to 2010. “It

IPO 116

IPO Portfolio Trading Business 116

InvestmentBank.com

JANUARY 14, 2021

YoY decline in the total monetary value of VC investments compared to Q2 2019 and an 18.0% YoY in total value compared to 2019 and down only 11.3% Second, the IPO market, a key exit avenue for VC investments, proved increasingly strong and resilient throughout the year. These were just a few of many strong IPOs seen this year.

Capital 40

Capital IPO S&P Hospitality 40

Cooley M&A

SEPTEMBER 16, 2022

There are compelling rationales for adopting a dual-class structure, but even proponents of the structure generally acknowledge that these benefits are significantly mitigated once the dual-class shares are out of the hands of the founders and/or pre-IPO stockholders. Potential carve outs for M&A voting agreements. Stockholder litigation.

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

The Deal

AUGUST 9, 2023

Our acquisition strategy is aligned with acquiring companies with a traditional product portfolio, who have success and marquee customer relationships that we can transform with our AI platform,” SymphonyAI CEO Sanjay Dhawan told The Deal. Following acquisitions, the company develops AI applications for the target’s clients.

M&A 40

M&A Private Equity Retail Financial Services 40

Cooley M&A

JANUARY 23, 2024

Strained access to public markets and funding The IPO market remained relatively inactive in 2023, leading many life sciences companies looking to raise funds to turn to other exit strategies. Additional major acquisitions of 2023 included Pfizer’s acquisition of Seagen for $43 billion and Merck’s acquisition of Prometheus for $10.8

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52